A detailed history of Bank Of America Corp transactions in Eton Pharmaceuticals, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 183 shares of ETON stock, worth $1,586. This represents 0.0% of its overall portfolio holdings.

Number of Shares
183
Holding current value
$1,586
% of portfolio
0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$3.06 - $3.75 $559 - $686
183 New
183 $0
Q4 2023

Feb 14, 2024

BUY
$3.45 - $4.66 $96 - $130
28 New
28 $0
Q4 2022

Feb 10, 2023

BUY
$2.02 - $3.25 $101 - $162
50 New
50 $0
Q1 2022

May 16, 2022

SELL
$3.43 - $4.69 $1,125 - $1,538
-328 Closed
0 $0
Q4 2021

Feb 08, 2022

SELL
$3.66 - $6.59 $111,941 - $201,555
-30,585 Reduced 98.94%
328 $1,000
Q3 2021

Nov 15, 2021

BUY
$4.2 - $6.26 $50,467 - $75,220
12,016 Added 63.59%
30,913 $156,000
Q2 2021

Sep 13, 2021

BUY
$5.71 - $8.85 $107,901 - $167,238
18,897 New
18,897 $116,000

Others Institutions Holding ETON

About Eton Pharmaceuticals, Inc.


  • Ticker ETON
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,297,000
  • Market Cap $219M
  • Description
  • Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...
More about ETON
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.